HALOZYME REPORTS THIRD QUARTER 2022 FINANCIAL AND OPERATING RESULTS
Go back to HALOZYME REPORTS THIRD QUARTER 2022 FINANCIAL AND OPERATING RESULTS| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 74.97 -0.08 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $75.05 | 52 Week High | $18.39 | |||
| Open | $74.62 | 52 Week Low | $6.96 | |||
| Day High | $75.09 | P/E | N/A | |||
| Day Low | $73.89 | EPS | $-0.58 | |||
| Volume | 94,427 | |||||

